MSE
ALXN

MUFG Securities EMEA’s Alexion Pharmaceuticals ALXN Stock Holding History

MUFG Securities EMEA’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-406,000
Closed -$74.6M – 382
2021
Q2 		$74.6M Buy
406,000
+148,000
+57% +$25.4M 0.81% 26
2021
Q1 		$39.5M Buy
+258,000
New +$39.9M 0.35% 71
2020
Q2 		– Sell
-112,000
Closed -$10.1M – 532
2020
Q1 		$10.1M Buy
112,000
+66,000
+143% +$6.48M 0.1% 147
2019
Q4 		$4.97M Buy
46,000
+38,400
+505% +$4.11M 0.04% 279
2019
Q3 		$744K Sell
7,600
-67,400
-90% -$7.6M 0.01% 286
2019
Q2 		$9.82M Buy
+75,000
New +$9.67M 0.11% 134
2018
Q4 		– Sell
-6,042
Closed -$840K – 763
2018
Q3 		$840K Buy
6,042
+5,793
+2,327% +$727K 0.01% 361
2018
Q2 		$31K Buy
+249
New +$29.1K ﹤0.01% 347

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return